Charles River Laboratories CRL shares rallied 6.9% in the last trading session to close at $106.60. This move can be attributable to notable volume with a higher number of shares being traded than in ...

One way we can try to measure the level of fear in a given stock is ... In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) entered into oversold territory ...

Adjusted operating income totaled $88.5 million, reflecting a 47% decline from the prior-year quarter’s level. The adjusted ...

We recently published a list of Traders Heavily Sold Down These 10 Stocks on Thursday. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) ...

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and ...

Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...

Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund.

For Charles River, the consensus EPS estimate for the quarter has been revised 0.9% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't ...